Navigation Links
Pharmacyclics to Host a Conference Call on March 15, 2012 to Discuss Second Quarter Fiscal 2012 Financial and Operational Results
Date:3/1/2012

SUNNYVALE, Calif., March 1, 2012 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer and immune mediated diseases, today announced that senior management will host a conference call on Thursday, March 15th, at 1:30 pm PST to discuss the company's second quarter fiscal 2012 financial and operational results as previously announced.Conference Call Details: Date: Thursday March 15, 2012Time: 1:30 pm PSTListen via Internet: http://ir.pharmacyclics.com/events.cfmToll-free: +1-877-407-8133International: +1-201-689-8040The webcast replay will be available for 30 days on the Investor Relations section of the company's Web site at www.pharmacyclics.com.

About PharmacyclicsPharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medial healthcare needs; and to identify promising product candidates based on scientific development expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.

Presently, Pharmacyclics has three product candidates in clinical development and several preclinical molecules in lead optimization. We are committed to high standards of ethics, scientific rigor, and operational efficiency as we move each of these programs to viable commercialization.

The Company is headquartered in
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
5. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
6. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
7. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
8. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
11. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... ARBOR, Mich. , July 30, 2014 Advanced ... first quarter (ending June 27, 2014) financial results on Monday, ... will be released after the close of the market and ... discuss the results at 4:30 p.m. EDT on the same ... Richard Kurtz (CEO and Director), Rob Risser ...
(Date:7/30/2014)... , July 30, 2014 In conjunction with ... 2014 financial results press release, you are invited to ... live over the internet on Thursday, August 7, 2014 ... A live audio webcast of the presentation ... http://www.durect.com and clicking "Investor Relations."  If you are ...
(Date:7/30/2014)... July 30, 2014 Research and Markets has ... - Forecasts to 2019" report to their offering. ... estimated to grow at a lower CAGR in developed countries; however, ... as China , India , ... The growth of the hematology analyzers and reagents market ...
Breaking Medicine Technology:Advanced Photonix to Webcast Fiscal 2015 First Quarter Earnings 2DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call 2Hematology Analyzers & Reagents Market - Forecasts to 2019 2
(Date:7/30/2014)... July 30, 2014 Good Neighbor ... in an upcoming episode of Innovations with Ed ... Channel. Dates and show times TBA. , In ... Neighbor Community Services’ vision to redefine the traditional ... and dynamic services. Through passion, innovation, determination, excellence, ...
(Date:7/30/2014)... WEDNESDAY, July 30, 2014 (HealthDay News) -- It can happen ... television, dresser or computer monitor and gets critically injured ... of a young child should look around their homes and ... a child. Imagining it is better than it becoming a ... Emergency Physicians, said in a college news release. Between ...
(Date:7/30/2014)... as well as evolutionary changes in a living organismhad ... throughout the genome. , However, recent studies have shown ... mutations that arise simultaneously and in close proximity to ... found in regions where chromosomal rearrangements take place. , ... , may one day lead to new cancer therapies, ...
(Date:7/30/2014)... July 30, 2014 Visitors to our ... over $8,500 to ensure its protection. Bob Kiesendahl, one ... check to the Delaware Highlands Conservancy for donations collected ... small $2-per-stay donations add up fast, as visitors welcome ... Upper Delaware River Region. , The Kiesendahl family has ...
(Date:7/30/2014)... 2014) The phrase "we caught it early" is possibly ... midst of a cancer diagnosis. Combating cancer in its ... certain part of the body, gives patients the best ... colon, prostate and other forms of cancer are touted ... providers recommend cancer screenings as a precautionary measure, especially ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2Health News:Tip-Over Furniture Can Kill Kids 2Health News:Biologists describe mechanism promoting multiple DNA mutations 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 3
... July 8 Fate Therapeutics, Inc. ... research on small molecule modulators of the Wnt pathway ... International Society for Stem Cell Research (ISSCR) in Barcelona, ... selected Wnt activators induce the differentiation of mesenchymal stem ...
... ... a name change to Freedom Disability and has expanded its operations into a new corporate ... growth of the business, bringing hundreds of new jobs to the state. , ... Shelton, CT (PRWEB) July 8, 2009 -- ...
... , HUNTINGTON BEACH, Calif., July 8 "You are what you ... what you drink may be as important as what you eat ... and many others, according to Dr. Cheryle Hart, medical advisor for ... . , , One study referred ...
... ... according to Ed Sinson, On-line Forum and Social Networking Representative. , ... Irvine, Calif. (Vocus) July 8, 2009 ... according to Ed Sinson, On-line Forum and Social Networking Representative. , , ,"We ...
... ... Parts Washers are growing in popularity. These parts washers are cost effective and quick ... economic climate. , ... (Vocus) July 8, 2009 -- Midbrook, a Jackson, MI based manufacturer of industrial parts ...
... created using embryonic stem cells for the first time in ... understanding of the causes of infertility. Researchers led ... England Stem Cell Institute (NESCI) have developed a new technique ... the laboratory. The work is published today (8th ...
Cached Medicine News:Health News:Fate Therapeutics to Present Data on Stimulation of Osteogenic Activity Using Small Molecule Modulators of Wnt Pathway 2Health News:National Social Security Disability Advocacy Firm Changes Name to "Freedom Disability" and Acquires 22,000 Square Foot Corporate Headquarters in Shelton, CT 2Health News:National Social Security Disability Advocacy Firm Changes Name to "Freedom Disability" and Acquires 22,000 Square Foot Corporate Headquarters in Shelton, CT 3Health News:Latest Studies Show 'Junk Drinks' Pose as Many Health Threats as 'Junk Food' According to AquaHydrate Medical Advisor 2Health News:Latest Studies Show 'Junk Drinks' Pose as Many Health Threats as 'Junk Food' According to AquaHydrate Medical Advisor 3Health News:Latest Studies Show 'Junk Drinks' Pose as Many Health Threats as 'Junk Food' According to AquaHydrate Medical Advisor 4Health News:Bariatric Advantage Participates in Social Networks 2Health News:Refurbished and Used Industrial Parts Washers Grow in Popularity 2Health News:Human sperm created from embryonic stem cells 2
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Medicine Products: